"Schistosomiasis mansoni" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Schistosomiasis caused by Schistosoma mansoni. It is endemic in Africa, the Middle East, South America, and the Caribbean and affects mainly the bowel, spleen, and liver.
| Descriptor ID |
D012555
|
| MeSH Number(s) |
C03.335.865.859.576
|
| Concept/Terms |
Schistosomiasis mansoni- Schistosomiasis mansoni
- Schistosoma mansoni Infection
- Infection, Schistosoma mansoni
- Infections, Schistosoma mansoni
- Schistosoma mansoni Infections
|
Below are MeSH descriptors whose meaning is more general than "Schistosomiasis mansoni".
Below are MeSH descriptors whose meaning is more specific than "Schistosomiasis mansoni".
This graph shows the total number of publications written about "Schistosomiasis mansoni" by people in this website by year, and whether "Schistosomiasis mansoni" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2011 | 1 | 0 | 1 |
| 2014 | 2 | 0 | 2 |
| 2016 | 1 | 0 | 1 |
| 2018 | 1 | 0 | 1 |
| 2020 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Schistosomiasis mansoni" by people in Profiles.
-
Fifteen Years of Sm-p80-Based Vaccine Trials in Nonhuman Primates: Antibodies From Vaccinated Baboons Confer Protection in vivo and in vitro From Schistosoma mansoni and Identification of Putative Correlative Markers of Protection. Front Immunol. 2020; 11:1246.
-
Sm-p80-based vaccine trial in baboons: efficacy when mimicking natural conditions of chronic disease, praziquantel therapy, immunization, and Schistosoma mansoni re-encounter. Ann N Y Acad Sci. 2018 08; 1425(1):19-37.
-
Discovery of Antischistosomal Drug Leads Based on Tetraazamacrocyclic Derivatives and Their Metal Complexes. Antimicrob Agents Chemother. 2016 09; 60(9):5331-6.
-
Longevity of Sm-p80-specific antibody responses following vaccination with Sm-p80 vaccine in mice and baboons and transplacental transfer of Sm-p80-specific antibodies in a baboon. Parasitol Res. 2014 Jun; 113(6):2239-50.
-
Use of an Sm-p80-based therapeutic vaccine to kill established adult schistosome parasites in chronically infected baboons. J Infect Dis. 2014 Jun 15; 209(12):1929-40.
-
Preclinical prophylactic efficacy testing of Sm-p80-based vaccine in a nonhuman primate model of Schistosoma mansoni infection and immunoglobulin G and E responses to Sm-p80 in human serum samples from an area where schistosomiasis is endemic. J Infect Dis. 2011 Nov; 204(9):1437-49.